| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Edelstein David Benjamin | EVP, Chief Innovation Officer | 105 W 8TH ST, PORT ANGELES | /s/ Allison R. Mahaney, Attorney-in-Fact for David B. Edelstein | 10 Mar 2026 | 0002018240 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FNWB | Common Stock | Award | +4,698 | +44% | $9.18* | 15,452 | 07 Mar 2026 | Direct | F1, F2 | |
| transaction | FNWB | Common Stock | Disposed to Issuer | -393 | -2.5% | $9.18* | 15,059 | 07 Mar 2026 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents an award of restricted stock under the Issuer's 2020 Equity Incentive Plan ("2020 Plan"), one-third of which will vest annually beginning on March 7, 2027. |
| F2 | Includes 5,000 unvested shares of restricted stock granted under the Issuer's 2020 Plan, one-half of which will vest annually beginning on May 7, 2026; 2,575 unvested shares of restricted stock granted under the Issuer's 2020 Plan, one-half of which will vest annually beginning on March 7, 2027; and 4,698 unvested shares of restricted stock granted under the Issuer's 2020 Plan, one-third of which will vest annually beginning on March 7, 2027. |